跳至主要内容
临床试验/NL-OMON53363
NL-OMON53363招募中4 期

Probiotic formulation for patients with schizophrenia or bipolar disorder who have screened positive for increased intestinal permeability<br> - GUTS

niversitair Medisch Centrum Groningen0 个研究点目标入组 145 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
145

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1.Age 18-65 years;2.The participant understands the study and is capable of providing written informed consent;3.The participant has a DSM-IV-R or DSM-5 diagnosis of: 295.x (schizophrenia, schizophreniform disorder or schizo-affective disorder) or bipolar disorder 296.x;4.Serum LPS-binding protein (LBP) values of 9 ng/ml or higher

排除标准

  • 1.Pregnancy or breastfeeding;2.Mental retardation (IQ score <60);3.Active liver-, kidney- or pancreas disease as defined by ALAT > two times the upper boundary of normal levels;4.Any clinically significant or unstable medical disorder as determined by the investigators, including IBD, short-bowel syndrome or acute/chronic pancreatitis

研究者

相似试验

Probiotic formulation for patients with... | 临床试验